Materialise expands its cardiovascular solutions with the acquisition of FEops

Materialise, a leading provider of 3D printing software and services, has acquired the Belgian company FEops, which develops AI-driven simulation technology for structural heart interventions. With this acquisition, Materialise expands its cardiovascular solutions with predictive simulation capabilities and advances the personalized treatment of heart disease. The transaction amount was not disclosed.

Through 3D technologies, Materialise enables customized treatment plans tailored to patients’ individual anatomy. FEops uses predictive simulation and AI to more accurately predict the interaction of transcatheter cardiac devices with patient anatomy. Materialise’s Mimics Planner, a leading tool for anatomical analysis and planning, is enhanced by the integration of FEops. This allows clinicians to simulate the interaction between medical devices and patient anatomy.

“At Materialise, we are pioneering the advent of mass-personalization in healthcare, using advanced visualization and 3D printing technologies to deliver precise, patient-specific solutions,” said Brigitte de Vet, CEO of Materialise. “By integrating FEops’ advanced predictive simulation technology with our Mimics Planner, we are expanding our cardiovascular solutions to provide clinicians with comprehensive insights into patient anatomy. This integration will not only enhance the accuracy and efficiency of structural heart interventions but also improve clinical outcomes and patient safety.”

Transcatheter procedures, once reserved for complex cases, are becoming more common but remain challenging. Improved simulation technologies are optimizing the clinical workflow and expanding the availability of these procedures.

Structural heart disease, such as valvular heart disease, leads the world in cardiovascular morbidity and mortality. Currently, 47 million people suffer from valvular heart disease, and by 2030, the annual cost of adverse events is estimated at USD 70 billion.

Materialise is driving mass personalization in healthcare through image-based 3D models for precise, patient-specific treatments. This improves outcomes and makes personalized healthcare more efficient and accessible.